GO:0043795 glyceraldehyde oxidoreductase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043795 (glyceraldehyde oxidoreductase activity) catalyzes the reaction A + D-glyceraldehyde + H2O = (R)-glycerate + AH2 + H+, as defined by QuickGO.
• This activity is distinct from glyceraldehyde-3-phosphate dehydrogenase (GAPDH) because it acts on free D-glyceraldehyde rather than glyceraldehyde-3-phosphate.
• Tungsten-dependent oxidoreductases, such as glyceraldehyde-3-phosphate ferredoxin oxidoreductase (GAPOR), provide mechanistic models for this class of enzymes.
• GAPDH, a related but distinct enzyme, is a key model for studying oxidoreductase regulation and has been linked to trinucleotide repeat disorders and anesthetic modulation.
• Studying GO:0043795 requires careful distinction from GAPDH and other aldehyde-oxidizing enzymes, using substrate-specific assays and genetic models.
• CRISPR knockout, point-mutation, and knock-in models are essential to establish causality for genes annotated with glyceraldehyde oxidoreductase activity.
Description
Glyceraldehyde oxidoreductase activity (GO:0043795) is a molecular function defined by the catalytic reaction A + D-glyceraldehyde + H2O = (R)-glycerate + AH2 + H+. This activity belongs to the oxidoreductase class, enzymes that transfer electrons from a donor to an acceptor, and it specifically oxidizes the aldehyde group of D-glyceraldehyde to a carboxylate, producing (R)-glycerate. Unlike the well-known glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which acts on glyceraldehyde-3-phosphate, GO:0043795 acts on free D-glyceraldehyde. This distinction is critical for accurate annotation and experimental design. Researchers study this activity to understand aldehyde metabolism, redox balance, and the roles of tungsten- and molybdenum-dependent enzymes in microbial and eukaryotic systems. The reaction is also relevant to biotechnological applications, such as chiral alcohol production and bioremediation, because it generates (R)-glycerate, a valuable building block. In this article, we integrate the QuickGO definition with verified literature to provide a research-grade overview of GO:0043795, its genes, mechanisms, disease links, and methods for functional validation.
glyceraldehyde oxidoreductase activity At A Glance
| GO ID | GO:0043795 |
|---|---|
| GO term | glyceraldehyde oxidoreductase activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Catalysis of the reaction: A + D-glyceraldehyde + H2O = (R)-glycerate + AH2 + H+. |
| Major function | Oxidation of D-glyceraldehyde to (R)-glycerate with concomitant reduction of an electron acceptor. |
| Reaction direction | Forward: aldehyde oxidation; reverse: (R)-glycerate reduction. |
| Substrate | D-glyceraldehyde |
| Product | (R)-glycerate |
| Cofactor requirement | Variable; some enzymes use tungsten or molybdenum cofactors. |
| Related activity | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) acts on glyceraldehyde-3-phosphate, not free D-glyceraldehyde. |
What Is GO:0043795?
GO:0043795, glyceraldehyde oxidoreductase activity, is defined by the chemical reaction: A + D-glyceraldehyde + H2O = (R)-glycerate + AH2 + H+. In this reaction, D-glyceraldehyde is oxidized to (R)-glycerate, water is consumed, and an electron acceptor (A) is reduced to AH2, releasing a proton (H+). The term describes the catalytic function of enzymes that perform this specific oxidoreduction. It is a molecular_function term in the Gene Ontology and is distinct from glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity, which uses glyceraldehyde-3-phosphate as substrate. The definition does not specify the identity of the electron acceptor (A), which can vary among enzymes, including ferredoxin, NAD(P)+, or other physiological acceptors.
Why Is glyceraldehyde oxidoreductase activity Important in Cell Biology?
GO:0043795 is important because it defines a specific aldehyde oxidation reaction that contributes to cellular redox homeostasis and carbon metabolism. Enzymes with this activity can detoxify reactive aldehydes, generate (R)-glycerate for metabolic pathways, and participate in energy conservation in anaerobic microorganisms. In biomedical research, understanding this activity helps distinguish it from GAPDH, a moonlighting enzyme implicated in neurodegeneration and cancer. Moreover, tungsten-dependent oxidoreductases, which often catalyze similar reactions, are models for studying metalloenzyme mechanisms and for developing biocatalysts. Accurate annotation of GO:0043795 is therefore essential for functional genomics, enzyme engineering, and disease-related studies.
• Defines a unique aldehyde oxidation reaction distinct from GAPDH and other glycolytic enzymes.
• Contributes to (R)-glycerate production, a chiral building block for chemical synthesis.
• Involved in redox balance and aldehyde detoxification in microbial and eukaryotic cells.
• Provides a model for tungsten- and molybdenum-dependent enzyme mechanisms.
• Helps interpret metabolic flux in anaerobic archaea and bacteria.
• Supports functional annotation in genome sequencing projects.
• Guides enzyme engineering for industrial biocatalysis.
• Aids in distinguishing GAPDH from related oxidoreductases in disease studies.
• Enables CRISPR-based validation of candidate genes annotated with this activity.
• Facilitates cross-species comparison of aldehyde metabolism.
Molecular Mechanism of glyceraldehyde oxidoreductase activity
Substrate binding and specificity
In simple terms: The enzyme grabs D-glyceraldehyde and holds it in place for oxidation.
Enzymes with glyceraldehyde oxidoreductase activity bind D-glyceraldehyde as their primary substrate. The binding site is stereospecific, ensuring that only the D-enantiomer is oxidized to (R)-glycerate. This specificity distinguishes GO:0043795 from GAPDH, which requires glyceraldehyde-3-phosphate. The reaction consumes water and produces (R)-glycerate, a proton, and a reduced electron acceptor. Structural studies of related tungsten enzymes suggest that the aldehyde group coordinates to a metal center before oxidation.
Catalytic mechanism and electron transfer
In simple terms: The enzyme removes electrons from the aldehyde and passes them to an acceptor molecule.
The catalytic cycle begins with the formation of a substrate-enzyme complex. Oxidation of D-glyceraldehyde involves the transfer of hydride or electrons to an electron acceptor (A), which is reduced to AH2. In tungsten-dependent enzymes such as glyceraldehyde-3-phosphate ferredoxin oxidoreductase (GAPOR), the tungsten center facilitates electron transfer to ferredoxin. The reaction also requires water, which provides the oxygen for the carboxylate group of (R)-glycerate. The overall reaction is: A + D-glyceraldehyde + H2O = (R)-glycerate + AH2 + H+.
Cofactors and metal centers
In simple terms: Some versions of this enzyme use metals like tungsten to help with the reaction.
Many enzymes exhibiting glyceraldehyde oxidoreductase activity are metalloenzymes. Tungsten-containing oxidoreductases, such as GAPOR from Pyrococcus furiosus, use a tungsten-pterin cofactor to catalyze the oxidation of glyceraldehyde-3-phosphate, a related substrate. Although GAPOR acts on glyceraldehyde-3-phosphate, its mechanism provides a paradigm for aldehyde oxidation by tungsten enzymes. Molybdenum-dependent enzymes can also catalyze similar reactions. The metal center cycles between oxidation states to accept electrons from the substrate and transfer them to the acceptor.
Regulation and cellular context
In simple terms: The activity can be turned up or down depending on the cell's needs.
The regulation of glyceraldehyde oxidoreductase activity is not well characterized for all enzymes, but general principles from related oxidoreductases apply. GAPDH, a related enzyme, is regulated by post-translational modifications, including S-nitrosylation and phosphorylation, and its activity can be modulated by anesthetics such as sevoflurane. In trinucleotide repeat disorders, brain GAPDH activity is altered, suggesting disease-specific regulation. For GO:0043795, substrate availability, redox state, and metal cofactor availability likely influence activity. Future studies using CRISPR models will help define regulatory mechanisms.
Key Genes Involved in GO:0043795 glyceraldehyde oxidoreductase activity
The following genes and proteins are experimentally linked to glyceraldehyde oxidoreductase activity or its related metabolic pathways, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase; oxidizes glyceraldehyde-3-phosphate | Model for oxidoreductase regulation; linked to neurodegeneration |
| GAPOR | Glyceraldehyde-3-phosphate ferredoxin oxidoreductase; tungsten-containing enzyme | Paradigm for tungsten-dependent aldehyde oxidation |
| DsbC | Disulfide bond isomerase with chaperone activity | Example of a moonlighting oxidoreductase |
| ALDH | Aldehyde dehydrogenase family; oxidizes aldehydes | Related aldehyde oxidation pathways |
| AOX | Aldehyde oxidase; molybdenum-containing enzyme | Catalyzes similar aldehyde oxidations |
| XDH | Xanthine dehydrogenase; molybdenum enzyme | Model for molybdenum cofactor enzymes |
| FDX | Ferredoxin; electron acceptor for GAPOR | Electron transfer partner |
| Tungsten cofactor biosynthesis genes | Synthesis of tungsten-pterin cofactor | Required for GAPOR activity |
| Molybdenum cofactor genes | Synthesis of molybdopterin | Required for molybdenum enzymes |
| Pyrococcus furiosus GAPOR | Archaeal glyceraldehyde-3-phosphate oxidoreductase | Hyperthermophilic model |
| Rat liver NADPH-dependent enzyme | NADPH-D-glyceraldehyde 3-phosphate oxidoreductase | Tissue distribution study |
| Human GAPDH | Glycolytic enzyme with diverse functions | Disease associations |
| Sevoflurane targets | Anesthetic modulation of GAPDH | Pharmacological regulation |
| DsbC homologs | Protein folding catalysts | Chaperone activity |
| Aldehyde reductases | Reduce aldehydes to alcohols | Opposite direction of oxidoreductases |
| Glyoxylate pathway enzymes | Convert glycerate to other metabolites | Metabolic context |
| Tungsten transporters | Uptake of tungsten for cofactor synthesis | Metal homeostasis |
How Is glyceraldehyde oxidoreductase activity Regulated?
The regulation of glyceraldehyde oxidoreductase activity (GO:0043795) is not fully defined, but insights from related enzymes suggest multiple layers of control. GAPDH, a related oxidoreductase, is regulated by post-translational modifications such as S-nitrosylation, which inhibits its activity. Anesthetics like sevoflurane can modulate GAPDH activity, indicating pharmacological regulation. In trinucleotide repeat disorders, brain GAPDH activity is altered, suggesting disease-specific dysregulation. For tungsten-dependent enzymes, tungsten availability and cofactor biosynthesis regulate activity. Future studies using CRISPR-based knockouts of candidate genes will help elucidate the specific regulatory mechanisms for GO:0043795.
glyceraldehyde oxidoreductase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GAPDH | Trinucleotide repeat disorders; altered brain activity | Knockout mice; patient-derived neurons |
| GAPDH | Anesthetic modulation | Cell lines treated with sevoflurane |
| GAPOR | Archaeal glycolysis; potential antimicrobial target | Pyrococcus furiosus knockout |
| ALDH | Aldehyde detoxification; cancer | CRISPR knockout in cancer cells |
| Tungsten enzymes | Microbial metabolism | Knockout in archaea |
Neurodegenerative disorders
GAPDH, a related oxidoreductase, has been implicated in trinucleotide repeat disorders such as Huntington's disease and spinocerebellar ataxias. Postmortem brain studies show altered GAPDH activity in these conditions. Although GO:0043795 specifically refers to free D-glyceraldehyde oxidation, the overlap in substrate specificity and redox chemistry suggests that enzymes with this activity may contribute to neuronal redox imbalance. Further research is needed to determine whether GO:0043795 enzymes are directly involved.
Cancer metabolism
Cancer cells often reprogram metabolism to support rapid growth, and oxidoreductases play key roles in maintaining redox balance. GAPDH is overexpressed in many cancers and is a target for anticancer strategies. While direct evidence for GO:0043795 in cancer is limited, the production of (R)-glycerate and aldehyde detoxification could influence tumor microenvironment. CRISPR knockout of candidate genes in cancer cell lines can test this hypothesis.
Microbial infections and metabolism
Tungsten-dependent enzymes like GAPOR are essential for glycolysis in hyperthermophilic archaea such as Pyrococcus furiosus. These enzymes are potential targets for antimicrobials against archaeal or bacterial pathogens. Understanding GO:0043795 in microbial pathogens could reveal new drug targets.
From glyceraldehyde oxidoreductase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X have glyceraldehyde oxidoreductase activity? | CRISPR knockout cell line + substrate assay |
| What is the role of gene X in aldehyde detoxification? | Point-mutation knock-in of catalytic residue |
| How does gene X affect (R)-glycerate production? | Overexpression cell line + metabolomics |
| Is gene X essential for microbial growth? | Knockout in Pyrococcus furiosus |
| Does gene X regulate GAPDH activity? | Double knockout + activity assay |
| What is the subcellular localization of gene X? | Tagged knock-in (e.g., GFP) + imaging |
How to Study the glyceraldehyde oxidoreductase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay with D-glyceraldehyde | Oxidoreductase activity | Confirm GO:0043795 in cell lysates |
| GAPDH activity assay | Glyceraldehyde-3-phosphate oxidation | Distinguish from GO:0043795 |
| CRISPR knockout screen | Gene essentiality for activity | Identify novel genes |
| Metabolomics | (R)-glycerate levels | Quantify pathway output |
| Isotope tracing | Flux through reaction | Determine metabolic role |
| Western blot | Protein expression | Validate knockout/overexpression |
| Immunofluorescence | Subcellular localization | Tagged knock-in models |
| X-ray crystallography | 3D structure | Mechanistic studies |
Enzymatic activity assays
Direct measurement of glyceraldehyde oxidoreductase activity uses substrate D-glyceraldehyde and an electron acceptor, monitoring the formation of (R)-glycerate or reduction of the acceptor. For tungsten enzymes, assays often use ferredoxin as acceptor. GAPDH activity assays, which use glyceraldehyde-3-phosphate, must be distinguished.
Genetic and CRISPR screens
CRISPR knockout libraries can identify genes required for glyceraldehyde oxidoreductase activity. Point mutations in catalytic residues can abolish activity, confirming annotation. Overexpression models can test gain-of-function. These approaches are essential for causal inference.
Metabolomics and flux analysis
Metabolomics can quantify (R)-glycerate and related metabolites in cells with modified candidate genes. Isotope tracing can determine flux through the glyceraldehyde oxidoreductase reaction.
Structural and biophysical methods
X-ray crystallography and cryo-EM can reveal the active site and metal coordination of enzymes with this activity. These methods help explain substrate specificity and catalytic mechanism.
How CRISPR Can Be Used to Study GO:0043795 glyceraldehyde oxidoreductase activity
Knockout
CRISPR knockout of candidate genes is the gold standard to test whether a gene is required for glyceraldehyde oxidoreductase activity. For example, knocking out GAPOR in Pyrococcus furiosus would abolish glyceraldehyde-3-phosphate oxidation. In human cells, knockout of GAPDH reduces glycolytic flux and alters redox balance. Knockout models are essential for causal inference.
Point Mutation
Point mutations can be introduced to alter catalytic residues or cofactor-binding sites. For tungsten enzymes, mutating the tungsten-coordinating residues abolishes activity. In GAPDH, active-site cysteine mutation (C152S) eliminates dehydrogenase activity. These models help define structure-function relationships.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) allows visualization and purification of enzymes with glyceraldehyde oxidoreductase activity. Knock-in of disease-associated mutations can model human disorders. For example, knock-in of expanded polyglutamine tracts in GAPDH-interacting proteins can mimic neurodegeneration.
Overexpression
Overexpression of candidate genes can increase glyceraldehyde oxidoreductase activity, enabling gain-of-function studies. Overexpression of GAPDH in cancer cells promotes proliferation and redox adaptation. Overexpression models are useful for testing whether increased activity drives a phenotype.
How EDITGENE Supports glyceraldehyde oxidoreductase activity Research
Researchers studying glyceraldehyde oxidoreductase activity-related genes often need to determine whether a candidate gene is causally involved in the reaction, how mutations affect catalysis, and what cellular pathways depend on it. EDITGENE provides end-to-end CRISPR services to answer these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for glyceraldehyde oxidoreductase activity research.
Frequently Asked Questions About glyceraldehyde oxidoreductase activity
What is glyceraldehyde oxidoreductase activity?
Glyceraldehyde oxidoreductase activity (GO:0043795) is a molecular function that catalyzes the reaction A + D-glyceraldehyde + H2O = (R)-glycerate + AH2 + H+, as defined by QuickGO.
What genes are involved in glyceraldehyde oxidoreductase activity?
Genes include GAPDH, GAPOR, and various aldehyde dehydrogenases. GAPOR is a tungsten-containing enzyme from Pyrococcus furiosus, while GAPDH is a related but distinct glycolytic enzyme.
How is glyceraldehyde oxidoreductase activity different from GAPDH?
GAPDH acts on glyceraldehyde-3-phosphate, whereas GO:0043795 acts on free D-glyceraldehyde. They are distinct activities.
What diseases are linked to glyceraldehyde oxidoreductase activity?
Direct links are limited, but related enzymes like GAPDH are implicated in trinucleotide repeat disorders and cancer metabolism.
How can I measure glyceraldehyde oxidoreductase activity?
Use enzymatic assays with D-glyceraldehyde as substrate and a suitable electron acceptor, monitoring (R)-glycerate formation or acceptor reduction.
What cofactors are required for glyceraldehyde oxidoreductase activity?
Some enzymes require tungsten or molybdenum cofactors, while others use NAD(P)+ or ferredoxin.
Can CRISPR be used to study glyceraldehyde oxidoreductase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to study gene function related to this activity.
What is the reaction catalyzed by GO:0043795?
The reaction is: A + D-glyceraldehyde + H2O = (R)-glycerate + AH2 + H+.
Is glyceraldehyde oxidoreductase activity found in humans?
Related activities exist, but the specific free D-glyceraldehyde oxidation is not well characterized in humans. GAPDH is the closest human enzyme.
How do I choose a model system for studying glyceraldehyde oxidoreductase activity?
Consider the organism: Pyrococcus furiosus for tungsten enzymes, rat tissues for NADPH-dependent enzymes, or human cell lines for GAPDH-related studies.
Conclusion
Glyceraldehyde oxidoreductase activity (GO:0043795) represents a specific aldehyde oxidation reaction that is distinct from GAPDH and other glycolytic enzymes. Its study is important for understanding microbial metabolism, redox biology, and potential disease mechanisms. By combining QuickGO annotation with verified literature, researchers can design rigorous experiments using CRISPR models and enzymatic assays. EDITGENE provides the tools and expertise to accelerate this research.
References
- 1. Seidler NW. 2013. Multiple binding partners.. Adv Exp Med Biol 985:249-67 PMID: 22851452
- 2. Wood T. 1973. NADPH-D-glyceraldehyde 3-phosphate oxidoreductase activity in muscle and other tissues of the rat.. Biochem Biophys Res Commun 54(1):176-81 PMID: 4147477
- 3. Montllor-Albalate C et al.. 2023. Measuring the Oxidation State and Enzymatic Activity of Glyceraldehyde Phosphate Dehydrogenase (GAPDH).. Methods Mol Biol 2675:219-236 PMID: 37258767
- 4. Swearengin TA et al.. 2006. Sevoflurane modulates the activity of glyceraldehyde 3-phosphate dehydrogenase.. J Enzyme Inhib Med Chem 21(5):575-9 PMID: 17194030
- 5. Kish SJ et al.. 1998. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders.. Arch Neurol 55(10):1299-304 PMID: 9779656
- 6. Chen J et al.. 1999. Chaperone activity of DsbC.. J Biol Chem 274(28):19601-5 PMID: 10391895
- 7. Szaleniec M et al.. 2025. Obligately Tungsten-Dependent Enzymes─Catalytic Mechanisms, Models and Applications.. Biochemistry 64(10):2154-2172 PMID: 40323690
- 8. Mukund S et al.. 1995. Glyceraldehyde-3-phosphate ferredoxin oxidoreductase, a novel tungsten-containing enzyme with a potential glycolytic role in the hyperthermophilic archaeon Pyrococcus furiosus.. J Biol Chem 270(15):8389-92 PMID: 7721730
